Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience

Diagnostic Pathology

Table 3 Group III, cases diagnosed with endometrioid adenocarcinomas

Case no.	HER2/neu			Primary site	Histopathology diagnosis
Case no.	IHC	FISH	Result	Primary site	Type	FIGO	Nuc
1	0	1.4	NEG	Endometrium	ENAdCA	2	3
2	0	1.15	NEG	Endometrium	ENAdCA	2	2
3	0	1.05	NEG	Endometrium	ENAdCA	2	2
4	1+	0.98	NEG	Endometrium	ENAdCA	1	1
5	1+	0.98	NEG	Endometrium	ENAdCA	1	2
6	0	NP	NEG	Fallopian Tube	ENAdCA	2	2
7	1+	NP	NEG	Endometrium	ENAdCA	1	2
8	1+	1	NEG	Endometrium	ENAdCA	1	1
9	1+	NP	NEG	Endometrium	ENAdCA	2	2
10	1+	NP	NEG	Ovary	ENAdCA	3	3
11	0	NP	NEG	Endometrium	ENAdCA	1	1
12	1+	NP	NEG	Endometrium	ENAdCA	2	3
13	0	NP	NEG	Endometrium	ENAdCA	2	2
14	0	NP	NEG	Ovary	ENAdCA	3	3
15	1+	NP	NEG	Endometrium	ENAdCA	2	2
16	1+	NP	NEG	Endometrium	ENAdCA	2	2
17	1+	NP	NEG	Endometrium	ENAdCA	3	2
18	0	NP	NEG	Ovary	ENAdCA	3	3
19	1+	NP	NEG	Endometrium	ENAdCA	1	2
20	0	NP	NEG	Endometrium	ENAdCA	2	1
21	1+	NP	NEG	Endometrium	ENAdCA	1	2
22	1+	NP	NEG	Endometrium	ENAdCA	1	2
23	1+	NP	NEG	Endometrium	ENAdCA	1	1
24	1+	NP	NEG	Endometrium	ENAdCA	2	1
25	0	NP	NEG	Ovary	ENAdCA	3	3
26	1+	NP	NEG	Endometrium	ENAdCA	2	1
27	0	NP	NEG	Endometrium	ENAdCA	2	2
28	0	NP	NEG	Ovary	ENAdCA	3	3

IHC immunohistochemistry score, FISH fluorescence in-situ hybridization HER2/CEP17 ratio, FIGO FIGO grade, Nuc nuclear grade, NP not performed, NEG negative, ENAdCA endometrioid adenocarcinoma

ISSN: 1746-1596